LifeNet Health debuts PliaFX® Prime, world’s most-versatile osteobiologic

LifeNet Health debuts PliaFX® Prime, world’s most-versatile osteobiologic

LifeNet Health debuts PliaFX® Prime, world’s most-versatile osteobiologic
New technology to be showcased in exhibit (booth 2311) at NASS Annual Meeting Sept. 26-28

Los Angeles — Sept. 25, 2018 — LifeNet Health today announced the launch of PliaFX® Prime, an advanced biomaterial with unsurpassed versatility. Currently available in limited release, PliaFX Prime consists of 100 percent precision-engineered cortical fibers that provide moldable handling, without the use of additives found in putties. 

LifeNet Health’s LifeSciences Division features biologically precise research solutions at Society of Toxicology – TOX EXPO

LifeNet Health’s LifeSciences Division features biologically precise research solutions at Society of Toxicology – TOX EXPO

LifeNet Health’s LifeSciences Division features biologically precise research solutions at Society of Toxicology – TOX EXPO
Visit booth 1661 to learn about biologically relevant human tissue, cells and services for research and scientific investigation

LifeNet Health provides uncompromised fusion solution with launch of PliaFX® Strip

LifeNet Health provides uncompromised fusion solution with launch of PliaFX® Strip

Orlando, Fla. — Oct. 25, 2017 — LifeNet Health has introduced its latest allograft bone-healing solution, the PliaFX® Strip, offering optimized handling and effective performance in a convenient, preformed shape. It is the first in a new family of grafts composed of 100 percent cortical bone fibers, created using an exclusive, patented processing technology.

LifeNet Health continues strategic growth with Austrian tissue bank acquisition

LifeNet Health continues strategic growth with Austrian tissue bank acquisition

LifeNet Health continues strategic growth with
Austrian tissue bank acquisition

European headquarters in Vienna will serve as training, distribution center

 

Virginia Beach, Va. — Feb. 13, 2017 — LifeNet Health, a leading, non-profit regenerative medicine company, has completed an all-equity acquisition of Austrian tissue bank AlloTiss Gemeinnützige Gewebebank GmbH.

LifeNet Health expands operations in the Pacific Northwest to include production of ViviGen® Cellular Bone Matrix

LifeNet Health expands operations in the Pacific Northwest to include production of ViviGen® Cellular Bone Matrix

Renton, Wash. — Jan. 10, 2017 — LifeNet Health, the only full-service, non-profit tissue bank operating in the Pacific Northwest has begun production of ViviGen® Cellular Bone Matrix in its Northwest headquarters in Renton, Wash. ViviGen, an innovative cellular allograft developed by LifeNet Health, incorporates viable bone cells that support the healing process.

LifeNet Health expands regenerative medicine efforts with opening of Research Triangle Park, N.C., facility

LifeNet Health expands regenerative medicine efforts with opening of Research Triangle Park, N.C., facility

Virginia Beach, Va. — Nov. 2, 2016 — LifeNet Health is expanding its cell-based research and processing capacity with the opening of a facility in North Carolina’s Research Triangle Park (RTP), near Durham. It will be an extension of its flagship research center, the LifeNet Health Institute of Regenerative Medicine, located at the company’s headquarters in Virginia Beach, Va.